201 related articles for article (PubMed ID: 21984182)
1. αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.
Ruan Q; Han S; Jiang WG; Boulton ME; Chen ZJ; Law BK; Cai J
Mol Cancer Res; 2011 Dec; 9(12):1632-43. PubMed ID: 21984182
[TBL] [Abstract][Full Text] [Related]
2. Targeting the IRE1α/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization.
Liu L; Qi X; Chen Z; Shaw L; Cai J; Smith LH; Grant MB; Boulton ME
Am J Pathol; 2013 Apr; 182(4):1412-24. PubMed ID: 23395094
[TBL] [Abstract][Full Text] [Related]
3. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo.
Chen Z; Ruan Q; Han S; Xi L; Jiang W; Jiang H; Ostrov DA; Cai J
Breast Cancer Res Treat; 2014 May; 145(1):45-59. PubMed ID: 24710637
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
5. alphaB-crystallin regulation of angiogenesis by modulation of VEGF.
Kase S; He S; Sonoda S; Kitamura M; Spee C; Wawrousek E; Ryan SJ; Kannan R; Hinton DR
Blood; 2010 Apr; 115(16):3398-406. PubMed ID: 20023214
[TBL] [Abstract][Full Text] [Related]
6. alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis.
Dimberg A; Rylova S; Dieterich LC; Olsson AK; Schiller P; Wikner C; Bohman S; Botling J; Lukinius A; Wawrousek EF; Claesson-Welsh L
Blood; 2008 Feb; 111(4):2015-23. PubMed ID: 18063749
[TBL] [Abstract][Full Text] [Related]
7. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
8. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
9. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
[TBL] [Abstract][Full Text] [Related]
10. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
11. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
[TBL] [Abstract][Full Text] [Related]
13. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.
Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H
Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins protect pulmonary microvascular endothelial cells from apoptosis by upregulating α-B-crystallin.
Ciumas M; Eyries M; Poirier O; Maugenre S; Dierick F; Gambaryan N; Montagne K; Nadaud S; Soubrier F
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2577-84. PubMed ID: 24072698
[TBL] [Abstract][Full Text] [Related]
15. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
[TBL] [Abstract][Full Text] [Related]
16. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice.
Gu JW; Young E; Busby B; Covington J; Johnson JW
Cancer Biol Ther; 2009 Mar; 8(6):514-21. PubMed ID: 19242105
[TBL] [Abstract][Full Text] [Related]
18. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
20. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
